- Report
- May 2024
- 200 Pages
Global
From €3838EUR$4,150USD£3,208GBP
- Report
- May 2024
- 200 Pages
Global
From €3838EUR$4,150USD£3,208GBP
- Report
- October 2023
- 145 Pages
Global
From €2913EUR$3,150USD£2,435GBP
- Report
- August 2023
- 145 Pages
Global
From €2913EUR$3,150USD£2,435GBP
- Report
- August 2023
- 145 Pages
Global
From €2913EUR$3,150USD£2,435GBP
- Report
- August 2025
- 187 Pages
Global
From €3279EUR$3,545USD£2,740GBP
€3643EUR$3,939USD£3,045GBP
- Report
- August 2025
- 195 Pages
Global
From €3279EUR$3,545USD£2,740GBP
€3643EUR$3,939USD£3,045GBP
- Report
- August 2025
- 190 Pages
Global
From €3279EUR$3,545USD£2,740GBP
€3643EUR$3,939USD£3,045GBP
- Report
- August 2025
- 197 Pages
Global
From €3279EUR$3,545USD£2,740GBP
€3643EUR$3,939USD£3,045GBP
- Report
- August 2025
- 180 Pages
Global
From €3279EUR$3,545USD£2,740GBP
€3643EUR$3,939USD£3,045GBP
- Report
- August 2025
- 189 Pages
Global
From €3279EUR$3,545USD£2,740GBP
€3643EUR$3,939USD£3,045GBP
- Report
- July 2024
- 130 Pages
Global
From €4393EUR$4,750USD£3,672GBP
- Report
- April 2023
- 120 Pages
Global
From €4393EUR$4,750USD£3,672GBP
- Report
- July 2023
- 113 Pages
Global
From €4162EUR$4,500USD£3,479GBP
- Report
- August 2022
- 115 Pages
Global
From €4162EUR$4,500USD£3,479GBP
- Report
- July 2024
- 100 Pages
Global
From €3468EUR$3,750USD£2,899GBP
- Report
- June 2023
- 120 Pages
Germany
From €2579EUR$2,789USD£2,156GBP
- Report
- July 2025
- 350 Pages
Global
From €4577EUR$4,949USD£3,826GBP
- Report
- July 2024
- 200 Pages
Global
From €4577EUR$4,949USD£3,826GBP
- Report
- May 2023
- 147 Pages
Global
From €4577EUR$4,949USD£3,826GBP

The Transcriptomics market is a segment of the biotechnology industry that focuses on the study of gene expression. It involves the analysis of the transcriptome, which is the set of all RNA molecules in a cell. This includes mRNA, tRNA, and rRNA. Transcriptomics is used to study gene expression, regulation, and function. It is used to identify and characterize genes, as well as to understand the role of genes in disease and development. Transcriptomics can also be used to identify biomarkers for diagnosis and prognosis, and to develop new therapeutic targets.
Some companies in the Transcriptomics market include Illumina, Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, and QIAGEN. Show Less Read more